"DOJ and Pro-Life Advocates Clash Over Abortion Pill Access in Supreme Court Battle"

The Biden administration and Danco Laboratories have urged the Supreme Court to maintain broad access to the abortion pill, mifepristone, warning that restricting its availability would harm women seeking medication abortions. They defended the FDA's actions since 2016, which made the pill easier to obtain, and argued that limiting access to mifepristone would have damaging effects. The Supreme Court is set to hear arguments in a dispute brought by anti-abortion rights medical associations and doctors, with a decision expected by the end of June.